Table 2: Data Descriptions Used for the Machine Learning Study.
This table enlists all the datasets used during the responder/non-responder prediction across different cancer types.
Sr. No | Cancer Type | Treatment | Platform | Dataset Link | Reference |
---|---|---|---|---|---|
1 | BRCA | Neoadjuvant Doxorubicin/Cyclophosphamide followed by Ixabepilone or Paclitaxel |
Microarray | GSE41998 | Horak et.al. [40] |
Neoadjuvant taxane-based chemotherapy | RNA Sequencing | GSE163882 | Chen et.al. [41] | ||
Chemotherapy followed by Trastuzumab | Microarray | GSE66399 | Dinstag et.al. [42] | ||
Chemotherapy followed by Trastuzumab | Microarray | GSE37946 | Dinstag et.al [42] | ||
Neoadjuvant fluorouracil/epirubicin/cyclophosp hamide followed by Trastuzumab | Microarray | GSE42822 | Dinstag et.al [42] | ||
Neoadjuvant platinum & Bevacizumab | Microarray | GSE103668 | Dinstag et.al [42] | ||
Alpelisib | Dinstag et.al [42] | ||||
Chemotherapy followed by Lapatinib | Microarray | GSE66399 | Dinstag et.al [42] | ||
Neoadjuvant Herceptin followed by Trastuzumab | Microarray | GSE50948 | Dinstag et.al [42] | ||
Durvalumab with Olaparib | Microarray | GSE173839 | Dinstag et.al [42] | ||
2 | COAD | FOLFOX Therapy | Microarray | GSE28702 | Tsuji et.al. [43] |
FOLFIRI Therapy | Microarray | GSE62080 | Rio et.al. [44] | ||
3 | LIHC | Sorafenib as standard systemic therapy | RNA Sequencing | GSE109211 | Pinyol et.al. [45] |
4 | ESCA | Preoperative chemoradiotherapy followed by surgery | Microarray | GSE45670 | Wen et.al. [46] |